• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

探讨药物含量对 DPI 粉末性质的影响及肺部药物沉积的潜在预测。

Exploring the influence of drug content on DPI powder properties and potential prediction of pulmonary drug deposition.

机构信息

School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China.

Respirent Pharmaceuticals Co., Ltd, Chongqing 400714, China.

出版信息

Int J Pharm. 2020 Feb 15;575:119000. doi: 10.1016/j.ijpharm.2019.119000. Epub 2019 Dec 29.

DOI:10.1016/j.ijpharm.2019.119000
PMID:31893544
Abstract

Based on dry powder inhaler (DPI) inhalation process, powder properties have a key influence on fluidization and deagglomeration behavior during aerosol generation. The aim of this study was to explore the influence of drug content on DPI powder properties and further reveal the correlations between powder properties and pulmonary deposition efficiency. Using salbutamol sulfate as a model drug, Lactohale® 100 as carrier, carrier-based binary mixtures were prepared at drug content from 0.5 to 10% (w/w), characterized with powder rheometer, faraday cage and Next Generation Impactor. It was demonstrated that drug content had a remarkable influence on powder behavior, and good correlations between powder properties and fine particle fraction (FPF) were established in drug content range 0.5-7%. A negative correlation between basic flowability energy and FPF, reflected a good flowability is beneficial for powder fluidization. Further properties characterization, including aeration ratio, permeability, pre-shear stress and aerodynamic specific charge, suggested a strong interaction is beneficial for powder deagglomeration. It's the first time that interaction indicator and flowability indicator were extracted with principal component analysis (PCA). In conclusion, drug content has a significant influence on powder properties. DPI formulations with a stronger interaction and meanwhile a better flowability are desirable for enhanced pulmonary drug delivery.

摘要

基于干粉吸入器(DPI)的吸入过程,粉末特性对气溶胶生成过程中的流化和团聚体解聚行为有重要影响。本研究旨在探讨药物含量对 DPI 粉末特性的影响,并进一步揭示粉末特性与肺部沉积效率之间的相关性。以硫酸沙丁胺醇为模型药物,以 Lactohale®100 为载体,制备了药物含量从 0.5%到 10%(w/w)的载体制备二元混合物,采用粉末流变仪、法拉第笼和下一代撞击器进行了表征。结果表明,药物含量对粉末行为有显著影响,在 0.5%至 7%的药物含量范围内,建立了粉末特性与细颗粒分数(FPF)之间的良好相关性。基本流动性能量与 FPF 之间呈负相关,表明良好的流动性有利于粉末的流化。进一步的特性表征,包括通气比、渗透率、预剪切应力和空气动力学比电荷,表明强相互作用有利于粉末解团聚。这是首次采用主成分分析(PCA)提取相互作用指标和流动性指标。总之,药物含量对粉末特性有显著影响。对于增强肺部药物输送,具有更强相互作用同时具有更好流动性的 DPI 配方是理想的。

相似文献

1
Exploring the influence of drug content on DPI powder properties and potential prediction of pulmonary drug deposition.探讨药物含量对 DPI 粉末性质的影响及肺部药物沉积的潜在预测。
Int J Pharm. 2020 Feb 15;575:119000. doi: 10.1016/j.ijpharm.2019.119000. Epub 2019 Dec 29.
2
Elucidating the Effect of Fine Lactose Ratio on the Rheological Properties and Aerodynamic Behavior of Dry Powder for Inhalation.阐明细乳糖比例对吸入用干粉流变性能和空气动力学行为的影响。
AAPS J. 2021 Apr 15;23(3):55. doi: 10.1208/s12248-021-00582-0.
3
Exploring the potential influence of drug charge on downstream deposition behaviour of DPI powders.探讨药物电荷对 DPI 粉末下游沉积行为的潜在影响。
Int J Pharm. 2020 Oct 15;588:119798. doi: 10.1016/j.ijpharm.2020.119798. Epub 2020 Aug 21.
4
Elucidation of lactose fine size and drug shape on rheological properties and aerodynamic behavior of dry powders for inhalation.阐明乳糖的细微颗粒大小和药物形状对吸入干粉的流变性能和空气动力学行为的影响。
Eur J Pharm Biopharm. 2022 Oct;179:47-57. doi: 10.1016/j.ejpb.2022.08.007. Epub 2022 Aug 25.
5
Synergistic effect of magnesium stearate and fine lactose in improving aerosolization performance of fluticasone propionate in dry powder formulation.硬脂酸镁和细乳糖协同作用改善丙酸氟替卡松干粉制剂的雾化性能。
Int J Pharm. 2024 Oct 25;664:124609. doi: 10.1016/j.ijpharm.2024.124609. Epub 2024 Aug 18.
6
Exploring the influence of magnesium stearate content and mixing modality on the rheological properties and in vitro aerosolization of dry powder inhaler.探讨硬脂酸镁含量和混合方式对干粉吸入剂流变性能和体外雾化的影响。
Int J Pharm. 2023 Jul 25;642:123179. doi: 10.1016/j.ijpharm.2023.123179. Epub 2023 Jun 25.
7
Predicting in vitro lung deposition behavior of combined dry powder inhaler via rheological properties.通过流变学特性预测组合式干粉吸入器的体外肺部沉积行为。
Eur J Pharm Biopharm. 2022 Dec;181:195-206. doi: 10.1016/j.ejpb.2022.11.012. Epub 2022 Nov 15.
8
Powder flow analysis: A simple method to indicate the ideal amount of lactose fines in dry powder inhaler formulations.粉末流动分析:一种指示干粉吸入剂配方中乳糖细粉理想量的简单方法。
Int J Pharm. 2018 Jan 15;535(1-2):59-67. doi: 10.1016/j.ijpharm.2017.10.052. Epub 2017 Oct 31.
9
Preparation and Evaluation of Surface Modified Lactose Particles for Improved Performance of Fluticasone Propionate Dry Powder Inhaler.用于改善丙酸氟替卡松干粉吸入器性能的表面改性乳糖颗粒的制备与评价
J Aerosol Med Pulm Drug Deliv. 2015 Aug;28(4):254-67. doi: 10.1089/jamp.2014.1146. Epub 2014 Dec 17.
10
The influence of physical properties and morphology of crystallised lactose on delivery of salbutamol sulphate from dry powder inhalers.结晶乳糖的物理性质和形态对硫酸沙丁胺醇干粉吸入剂释药的影响。
Colloids Surf B Biointerfaces. 2012 Jan 1;89:29-39. doi: 10.1016/j.colsurfb.2011.08.019. Epub 2011 Sep 10.

引用本文的文献

1
Packing and flow performance of binary adhesive mixtures for inhalation of different drug loads and their relationships to aerosolisation.不同药物载量吸入用二元粘合剂混合物的填充和流动性能及其与雾化的关系。
Int J Pharm X. 2025 Jul 17;10:100358. doi: 10.1016/j.ijpx.2025.100358. eCollection 2025 Dec.
2
Pulmonary delivery of excipient-free tobramycin DPIs for the treatment of lung infection with CF.不含辅料的妥布霉素干粉吸入剂经肺部给药用于治疗囊性纤维化肺部感染。
Front Pharmacol. 2025 Jun 17;16:1528905. doi: 10.3389/fphar.2025.1528905. eCollection 2025.
3
Preparation of Carrier-Free Inhalable Dry Powder of Rivaroxaban Using Two-Step Milling for Lung-Targeted Delivery.
采用两步研磨法制备用于肺部靶向递送的无载体利伐沙班可吸入干粉
Pharmaceutics. 2025 May 9;17(5):634. doi: 10.3390/pharmaceutics17050634.
4
Development of a Spray-Dried Formulation of Peptide-DNA Nanoparticles into a Dry Powder for Pulmonary Delivery Using Factorial Design.采用析因设计法将肽-DNA 纳米粒喷雾干燥制成干粉用于肺部给药
Pharm Res. 2022 Jun;39(6):1215-1232. doi: 10.1007/s11095-022-03256-4. Epub 2022 Apr 19.
5
On the relationship between blend state and dispersibility of adhesive mixtures containing active pharmaceutical ingredients.含活性药物成分的粘合剂混合物的混合状态与分散性之间的关系
Int J Pharm X. 2020 Dec 24;3:100069. doi: 10.1016/j.ijpx.2020.100069. eCollection 2021 Dec.